Product catalog antigen listed by alphabetic starting with I
| Items 501 to 600 of 961 total | 10 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00008821-P01-25 | INPP4B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003632-Q01-10 | INPP5A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003632-Q01-25 | INPP5A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003636-Q01-10 | INPPL1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003636-Q01-25 | INPPL1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051141-P01-10 | INSIG2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051141-P01-25 | INSIG2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003641-P01-10 | INSL4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003641-P01-25 | INSL4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003645-Q01-10 | INSRR antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003645-Q01-25 | INSRR antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PA1100 | Insulin antigen | ||||||
| Human | Purified | >98% | E. coli | 25 mg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| PA1100X | Insulin antigen | ||||||
| Human | Purified | >98% | E. coli | 250 mg / US$ 515 | |||
| Acris Antibodies GmbH | |||||||
| PA1100XC | Insulin antigen | ||||||
| Human | Purified | >98% | E. coli | 1 g / ask | |||
| Acris Antibodies GmbH | |||||||
| 20801P-1000 | Insulin antigen | ||||||
| Human | >98% | E. coli | 1 g / --- | ||||
| QED Bioscience Inc. | |||||||
| 20801P-25 | Insulin antigen | ||||||
| Human | >98% | E. coli | 25 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 20801P-250 | Insulin antigen | ||||||
| Human | >98% | E. coli | 250 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 8I52 | Insulin-like Growth Factor Binding Protein 1 (IGFBP1) antigen | ||||||
| Human | > 90% | Amniotic Fluid | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| PA1062 | Insulin-like Growth Factor Binding Protein 3 (IGFBP3) antigen | ||||||
| Bovine | Purified | >98% | E. coli | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1062X | Insulin-like Growth Factor Binding Protein 3 (IGFBP3) antigen | ||||||
| Bovine | Purified | >98% | E. coli | 25 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1062XC | Insulin-like Growth Factor Binding Protein 3 (IGFBP3) antigen | ||||||
| Bovine | Purified | >98% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA280 | Insulin-like Growth Factor Binding Protein 3 (IGFBP3) antigen | ||||||
| Human | >98% | E. coli | 5 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA280X | Insulin-like Growth Factor Binding Protein 3 (IGFBP3) antigen | ||||||
| Human | >98% | E. coli | 25 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA071 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | >97% | E. coli | 20 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA071X | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | >97% | E. coli | 0.1 mg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PA1052 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Rat | Purified | >95% | E. coli | 20 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1052X | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Rat | Purified | >95% | E. coli | 0.1 mg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1052XC | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Rat | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA156 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Mouse | >98% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA156X | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Mouse | >98% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PR15022CF-250 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | Purified | >97% | E. coli | 0.25 mg / --- | |||
| Neuromics Antibodies | |||||||
| PR15022CF-50 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | Purified | >97% | E. coli | 50 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15023CF-50 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Mouse | Purified | >97% | E. coli | 50 µg / --- | |||
| Neuromics Antibodies | |||||||
| 20802P-100 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | >98% | E. coli | 0.1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 20802P-1000 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | >98% | E. coli | 1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 20802P-20 | Insulin-like Growth Factor I (IGF-I) antigen | ||||||
| Human | >98% | E. coli | 20 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| PA072 | Insulin-like Growth Factor II (IGF-II) antigen | ||||||
| Human | >97% | E. coli | 10 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA072X | Insulin-like Growth Factor II (IGF-II) antigen | ||||||
| Human | >97% | E. coli | 50 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| 20803P-10 | Insulin-like Growth Factor II (IGF-II) antigen | ||||||
| Human | >97% | E. coli | 10 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| 20803P-1000 | Insulin-like Growth Factor II (IGF-II) antigen | ||||||
| Human | >97% | E. coli | 1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 20803P-50 | Insulin-like Growth Factor II (IGF-II) antigen | ||||||
| Human | >97% | E. coli | 50 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| 10-288-22240F | Insulin-like growth factor-binding protein 6 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22240F-50 | Insulin-like growth factor-binding protein 6 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00009445-Q01-10 | Integral membrane protein 2B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009445-Q01-25 | Integral membrane protein 2B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026512-Q01-10 | Integrator complex subunit 6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026512-Q01-25 | Integrator complex subunit 6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX25215 | Integrin beta 1 peptide-phospho T788 + T789 (phospho and non-phospho pair) antigen | ||||||
| Purified | 1 packs / --- | ||||||
| GeneTex Inc. | |||||||
| GTX29661 | Interferon alpha protein antigen | ||||||
| 100 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29663 | Interferon beta protein antigen | ||||||
| 10 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX20645 | Interferon gamma protein antigen | ||||||
| 100 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29659 | Interferon gamma protein antigen | ||||||
| 100 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX29922 | Interferon gamma protein antigen | ||||||
| 100 µg / --- | |||||||
| GeneTex Inc. | |||||||
| PA1049 | Interferon tau antigen | ||||||
| Rat | Purified | >95% | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1049X | Interferon tau antigen | ||||||
| Rat | Purified | >95% | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1049XC | Interferon tau antigen | ||||||
| Rat | Purified | >95% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA068 | Interferon-alpha (IFN-alpha) antigen | ||||||
| Human | >98% | E. coli | 20 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA068X | Interferon-alpha (IFN-alpha) antigen | ||||||
| Human | >98% | E. coli | 0.1 mg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| SA027 | Interferon-alpha (IFN-alpha) antigen | ||||||
| Chicken | Purified | - | E. coli | 50 µg / US$ 585 | |||
| Acris Antibodies GmbH | |||||||
| PBL13100-1 | Interferon-alpha (IFN-alpha) antigen | ||||||
| Rat | >95% | Insect cells | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL15100-1 | Interferon-alpha (IFN-alpha) antigen | ||||||
| Feline | > 90% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL17100-1 | Interferon-alpha (IFN-alpha) antigen | ||||||
| Porcine | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11101-1 | Interferon-alpha (IFN-alpha)) carrier free antigen | ||||||
| Human | > 95% | E. coli | 5 µg / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11101-2 | Interferon-alpha (IFN-alpha)) carrier free antigen | ||||||
| Human | > 95% | E. coli | 20 µg / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12105-1 | Interferon-alpha 1 (IFN-a1) antigen | ||||||
| Mouse | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11175-1 | Interferon-alpha 1 (IFN-a1) (Ala114, IFN-aD) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12125-1 | Interferon-alpha 11 (IFN-a11) antigen | ||||||
| Mouse | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12130-1 | Interferon-alpha 13 (IFN-a13) antigen | ||||||
| Mouse | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PA1038 | Interferon-alpha 1b (IFN-a1b) antigen | ||||||
| Human | Purified | >98% | E. coli | 20 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1038X | Interferon-alpha 1b (IFN-a1b) antigen | ||||||
| Human | Purified | >98% | E. coli | 100 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1038XC | Interferon-alpha 1b (IFN-a1b) antigen | ||||||
| Human | Purified | >98% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PBL11105-1 | Interferon-alpha 2 (IFN-a2b) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL14110-1 | Interferon-alpha 2 (IFN-alpha2) antigen | ||||||
| Monkey | > 98% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL16100-1 | Interferon-alpha 2 (IFN-alpha2) [Ile 16] antigen | ||||||
| Monkey | > 98% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12110-1 | Interferon-alpha 4 (IFN-a4) antigen | ||||||
| Mouse | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11177-1 | Interferon-alpha 4a (IFN-a4a, IFN-aM1) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11180-1 | Interferon-alpha 4b (IFN-a4b) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PA1039 | Interferon-alpha A (IFN-a2a) antigen | ||||||
| Human | Purified | >98% | E. coli | 20 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1039X | Interferon-alpha A (IFN-a2a) antigen | ||||||
| Human | Purified | >98% | E. coli | 100 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1039XC | Interferon-alpha A (IFN-a2a) antigen | ||||||
| Human | Purified | >98% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PBL11100-1 | Interferon-alpha A (IFN-a2a) antigen | ||||||
| Human | > 95% | E. coli | 5000 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12100-1 | Interferon-alpha A (IFN-aA) antigen | ||||||
| Mouse | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PA1042 | Interferon-alpha B2 (IFN-a8) antigen | ||||||
| Human | Purified | >98% | E. coli | 20 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1042X | Interferon-alpha B2 (IFN-a8) antigen | ||||||
| Human | Purified | >98% | E. coli | 100 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1042XC | Interferon-alpha B2 (IFN-a8) antigen | ||||||
| Human | Purified | >98% | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PBL11115-1 | Interferon-alpha B2 (IFN-a8) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11120-1 | Interferon-alpha C (IFN-a10) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11125-1 | Interferon-alpha D (Val114IFN-a1) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11130-1 | Interferon-alpha F (IFN-a21) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11135-1 | Interferon-alpha G (IFN-a5) antigen | ||||||
| Human | > 95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11145-1 | Interferon-alpha H2 (IFN-a14) antigen | ||||||
| Human | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11150-1 | Interferon-alpha I (IFN-a17) antigen | ||||||
| Human | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11160-1 | Interferon-alpha J1 (IFN-a7) antigen | ||||||
| Human | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11165-1 | Interferon-alpha K (IFN-a6) antigen | ||||||
| Human | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11001-1 | Interferon-alpha sampler (12 species) antigen | ||||||
| Human | >95% | E. coli | 20 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL11190-1 | Interferon-alpha WA (IFN-a16) antigen | ||||||
| Human | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PA069 | Interferon-beta (IFN-beta) antigen | ||||||
| Human | >98% | E. coli | 2 µg / US$ 255 | ||||
| Acris Antibodies GmbH | |||||||
| PA069X | Interferon-beta (IFN-beta) antigen | ||||||
| Human | >98% | E. coli | 10 µg / US$ 355 | ||||
| Acris Antibodies GmbH | |||||||
| PBL12400-1 | Interferon-beta (IFN-beta) antigen | ||||||
| Mouse | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL13400-1 | Interferon-beta (IFN-beta) antigen | ||||||
| Rat | > 95% | CHO cells | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| PBL12401-1 | Interferon-beta (IFN-beta), carrier free antigen | ||||||
| Mouse | >95% | E. coli | 100 kU / --- | ||||
| PBL Biomedical Laboratories | |||||||
| Items 501 to 600 of 961 total | 10 Page(s): |



